Northwest Medical Isotopes, LLC, 101-102 [2015-33025]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 1 / Monday, January 4, 2016 / Notices (PDF) in accordance with NRC guidance available on the NRC’s public Web site at https://www.nrc.gov/site-help/esubmittals.html. A filing is considered complete at the time the documents are submitted through the NRC’s E-Filing system. To be timely, an electronic filing must be submitted to the E-Filing system no later than 11:59 p.m. Eastern Time on the due date. Upon receipt of a transmission, the E-Filing system time-stamps the document and sends the submitter an email notice confirming receipt of the document. The E-Filing system also distributes an email notice that provides access to the document to the NRC’s Office of the General Counsel and any others who have advised the Office of the Secretary that they wish to participate in the proceeding, so that the filer need not serve the documents on those participants separately. Therefore, applicants and other participants (or their counsel or representative) must apply for and receive a digital ID certificate before a hearing request/ petition to intervene is filed so that they can obtain access to the document via the E-Filing system. A person filing electronically using the NRC’s adjudicatory E-Filing system may seek assistance by contacting the NRC Meta System Help Desk through the ‘‘Contact Us’’ link located on the NRC’s public Web site at https:// www.nrc.gov/site-help/esubmittals.html, by email to MSHD.Resource@nrc.gov, or by a tollfree call at 1–866–672–7640. The NRC Meta System Help Desk is available between 8 a.m. and 8 p.m., Eastern Time, Monday through Friday, excluding government holidays. Participants who believe that they have a good cause for not submitting documents electronically must file an exemption request, in accordance with 10 CFR 2.302(g), with their initial paper filing requesting authorization to continue to submit documents in paper format. Such filings must be submitted by: (1) First class mail addressed to the Office of the Secretary of the Commission, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, Attention: Rulemaking and Adjudications Staff; or (2) courier, express mail, or expedited delivery service to the Office of the Secretary, Sixteenth Floor, One White Flint North, 11555 Rockville Pike, Rockville, Maryland, 20852, Attention: Rulemaking and Adjudications Staff. Participants filing a document in this manner are responsible for serving the document on all other participants. Filing is considered complete by firstclass mail as of the time of deposit in VerDate Sep<11>2014 16:43 Dec 31, 2015 Jkt 238001 the mail, or by courier, express mail, or expedited delivery service upon depositing the document with the provider of the service. A presiding officer, having granted an exemption request from using E-Filing, may require a participant or party to use E-Filing if the presiding officer subsequently determines that the reason for granting the exemption from use of E-Filing no longer exists. Documents submitted in adjudicatory proceedings will appear in the NRC’s electronic hearing docket which is available to the public at https:// ehd1.nrc.gov/ehd/, unless excluded pursuant to an order of the Commission, or the presiding officer. Participants are requested not to include personal privacy information, such as social security numbers, home addresses, or home phone numbers in their filings, unless an NRC regulation or other law requires submission of such information. However, a request to intervene will require including information on local residence in order to demonstrate a proximity assertion of interest in the proceeding. With respect to copyrighted works, except for limited excerpts that serve the purpose of the adjudicatory filings and would constitute a Fair Use application, participants are requested not to include copyrighted materials in their submission. The Commission will issue a notice or order granting or denying a hearing request or intervention petition, designating the issues for any hearing that will be held and designating the Presiding Officer. A notice granting a hearing will be published in the Federal Register and served on the parties to the hearing. For further details with respect to this application, see the application dated July 28, 2015 (ADAMS Accession No. ML15216A123), as supplemented on September 22, 2015 (ADAMS Accession No. ML15265A590). Dated at Rockville, Maryland, this 23rd day of December 2015. For the Nuclear Regulatory Commission. Theodore B Smith, Acting Chief, Reactor Decommissioning Branch, Division of Decommissioning, Uranium Recovery, and Waste Programs, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2015–33024 Filed 12–31–15; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 101 NUCLEAR REGULATORY COMMISSION [Docket No. 50–609; NRC–2013–0235] Northwest Medical Isotopes, LLC Nuclear Regulatory Commission. ACTION: Construction permit application; docketing. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has determined that the second and final part of the application for a construction permit, submitted by Northwest Medical Isotopes, LLC (NWMI) is acceptable for docketing. NWMI proposes to build a medical radioisotope production facility located in Columbia, Missouri. ADDRESSES: Please refer to Docket ID NRC–2013–0235 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0235. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced in this document (if that document is available in ADAMS) is provided the first time that a document is referenced. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear Reactor Regulation, telephone: 301– 415–2856; email: Michael.Balazik@ nrc.gov; U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. SUMMARY: E:\FR\FM\04JAN1.SGM 04JAN1 102 Federal Register / Vol. 81, No. 1 / Monday, January 4, 2016 / Notices By letter dated July 20, 2015 (ADAMS Accession No. ML15210A114), NWMI filed with the NRC, pursuant to Section 103 of the Atomic Energy Act of 1954, as amended (AEA), and part 50 of title 10 of the Code of Federal Regulations (10 CFR), ‘‘Domestic Licensing of Production and Utilization Facilities,’’ the second and final part of its two-part application for a construction permit for a medical radioisotope production facility. If granted, the construction permit would allow NWMI to construct a production facility in Columbia, Missouri. On June 8, 2015, the NRC published in the Federal Register its acceptance of part one of NWMI’s application for a construction permit (80 FR 32418). The NRC has completed its acceptance review of part two of NWMI’s application for a construction permit for a production facility as defined in 10 CFR 50.2, ‘‘Definitions.’’ The NRC has determined that part two was submitted in accordance with the requirements of 10 CFR 2.101(a)(5), completes the information required by 10 CFR 50.34(a), and is acceptable for docketing. NWMI’s construction permit application, in its entirety, has been placed under Docket No. 50–609. Please reference this docket number in all future correspondence. The NRC expects that NWMI will submit an application for fabricating low enriched uranium targets under 10 CFR part 70, ‘‘Domestic Licensing of Special Nuclear Materials,’’ as stated in paragraph six (page 2) of NWMI’s letter dated July 20, 2015. The NRC’s staff has started a review of the NWMI construction permit application. The NRC’s staff will provide NWMI with a schedule that identifies significant milestones and the expected review completion date. The schedule will include provisions for the NRC to request additional information, if necessary. A copy of the construction permit application will be referred to the Advisory Committee on Reactor Safeguards for a review and report consistent with 10 CFR 50.58, ‘‘Hearings and report of the Advisory Committee on Reactor Safeguards.’’ In support of the review of the NWMI construction permit application, a hearing will be conducted by the Commission or a Board designated by the Chief of the Atomic Safety and Licensing Board Panel in accordance with procedures in 10 CFR part 2, ‘‘Agency Rules of Practice and Procedure.’’ A future Federal Register notice (FRN) will announce the opportunity to petition for leave to intervene in a hearing on the tkelley on DSK3SPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 16:43 Dec 31, 2015 Jkt 238001 application as well as the time and place of the hearing. Additionally, in accordance with 10 CFR part 51, ‘‘Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions,’’ the NRC will also prepare an environmental impact statement for the proposed action. The environmental impact statement will evaluate the environmental impacts for construction, operation and decommissioning of NWMI’s radioisotope production facility. This review will cover all activities at NWMI’s radioisotope production facility, including those under 10 CFR parts 50 and 70. The docketing of the application does not predict whether the NRC will grant or deny the requested construction permit. If the NRC finds that NWMI’s construction permit application meets the applicable standards of the AEA and the NRC’s regulations, and that required notifications to other agencies and bodies have been made, the NRC will issue a construction permit for a production facility under 10 CFR part 50, in the form and containing conditions and limitations that the NRC finds appropriate and necessary. This notice only addresses the start of a review to determine whether the NRC will issue a construction permit for the proposed NWMI facility. In order to operate and produce radioisotopes in its facility, a separate application must be submitted by NWMI for the NRC’s review and approval, and, if docketed, would be the subject of a separate FRN. Dated at Rockville, Maryland, this 24 day of December, 2015. For the Nuclear Regulatory Commission. Michael F. Balazik, Chief (Acting), Research and Test Reactors Licensing Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation. [FR Doc. 2015–33025 Filed 12–31–15; 8:45 am] BILLING CODE 7590–01–P POSTAL REGULATORY COMMISSION [Docket Nos. MC2016–67 and CP2016–82; Order No. 2941] New Postal Product Postal Regulatory Commission. Notice. AGENCY: ACTION: The Commission is noticing a recent Postal Service filing concerning the addition of Priority Mail Contract 183 to the competitive product list. This notice informs the public of the filing, invites public comment, and takes other administrative steps. SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 DATES: Comments are due: January 5, 2016. Submit comments electronically via the Commission’s Filing Online system at https:// www.prc.gov. Those who cannot submit comments electronically should contact the person identified in the FOR FURTHER INFORMATION CONTACT section by telephone for advice on filing alternatives. ADDRESSES: FOR FURTHER INFORMATION CONTACT: David A. Trissell, General Counsel, at 202–789–6820. SUPPLEMENTARY INFORMATION: Table of Contents I. Introduction II. Notice of Commission Action III. Ordering Paragraphs I. Introduction In accordance with 39 U.S.C. 3642 and 39 CFR 3020.30 et seq., the Postal Service filed a formal request and associated supporting information to add Priority Mail Contract 183 to the competitive product list.1 The Postal Service contemporaneously filed a redacted contract related to the proposed new product under 39 U.S.C. 3632(b)(3) and 39 CFR 3015.5. Request, Attachment B. To support its Request, the Postal Service filed a copy of the contract, a copy of the Governors’ Decision authorizing the product, proposed changes to the Mail Classification Schedule, a Statement of Supporting Justification, a certification of compliance with 39 U.S.C. 3633(a), and an application for non-public treatment of certain materials. It also filed supporting financial workpapers. II. Notice of Commission Action The Commission establishes Docket Nos. MC2016–67 and CP2016–82 to consider the Request pertaining to the proposed Priority Mail Contract 183 product and the related contract, respectively. The Commission invites comments on whether the Postal Service’s filings in the captioned dockets are consistent with the policies of 39 U.S.C. 3632, 3633, or 3642, 39 CFR part 3015, and 39 CFR part 3020, subpart B. Comments are due no later than January 5, 2016. The public portions of these filings can be accessed via the Commission’s Web site (https://www.prc.gov). 1 Request of the United States Postal Service to Add Priority Mail Contract 183 to Competitive Product List and Notice of Filing (Under Seal) of Unredacted Governors’ Decision, Contract, and Supporting Data, December 24, 2015 (Request). E:\FR\FM\04JAN1.SGM 04JAN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 81, Number 1 (Monday, January 4, 2016)]
[Notices]
[Pages 101-102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-33025]

-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-609; NRC-2013-0235]

Northwest Medical Isotopes, LLC

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit application; docketing.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined
that the second and final part of the application for a construction
permit, submitted by Northwest Medical Isotopes, LLC (NWMI) is
acceptable for docketing. NWMI proposes to build a medical radioisotope
production facility located in Columbia, Missouri.

ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2013-0235. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The
ADAMS accession number for each document referenced in this document
(if that document is available in ADAMS) is provided the first time
that a document is referenced.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, telephone: 301-415-2856; email:
Michael.Balazik@nrc.gov; U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001.

[[Page 102]]

SUPPLEMENTARY INFORMATION: By letter dated July 20, 2015 (ADAMS
Accession No. ML15210A114), NWMI filed with the NRC, pursuant to
Section 103 of the Atomic Energy Act of 1954, as amended (AEA), and
part 50 of title 10 of the Code of Federal Regulations (10 CFR),
``Domestic Licensing of Production and Utilization Facilities,'' the
second and final part of its two-part application for a construction
permit for a medical radioisotope production facility. If granted, the
construction permit would allow NWMI to construct a production facility
in Columbia, Missouri. On June 8, 2015, the NRC published in the
Federal Register its acceptance of part one of NWMI's application for a
construction permit (80 FR 32418).
The NRC has completed its acceptance review of part two of NWMI's
application for a construction permit for a production facility as
defined in 10 CFR 50.2, ``Definitions.'' The NRC has determined that
part two was submitted in accordance with the requirements of 10 CFR
2.101(a)(5), completes the information required by 10 CFR 50.34(a), and
is acceptable for docketing. NWMI's construction permit application, in
its entirety, has been placed under Docket No. 50-609. Please reference
this docket number in all future correspondence.
The NRC expects that NWMI will submit an application for
fabricating low enriched uranium targets under 10 CFR part 70,
``Domestic Licensing of Special Nuclear Materials,'' as stated in
paragraph six (page 2) of NWMI's letter dated July 20, 2015.
The NRC's staff has started a review of the NWMI construction
permit application. The NRC's staff will provide NWMI with a schedule
that identifies significant milestones and the expected review
completion date. The schedule will include provisions for the NRC to
request additional information, if necessary.
A copy of the construction permit application will be referred to
the Advisory Committee on Reactor Safeguards for a review and report
consistent with 10 CFR 50.58, ``Hearings and report of the Advisory
Committee on Reactor Safeguards.''
In support of the review of the NWMI construction permit
application, a hearing will be conducted by the Commission or a Board
designated by the Chief of the Atomic Safety and Licensing Board Panel
in accordance with procedures in 10 CFR part 2, ``Agency Rules of
Practice and Procedure.'' A future Federal Register notice (FRN) will
announce the opportunity to petition for leave to intervene in a
hearing on the application as well as the time and place of the
hearing.
Additionally, in accordance with 10 CFR part 51, ``Environmental
Protection Regulations for Domestic Licensing and Related Regulatory
Functions,'' the NRC will also prepare an environmental impact
statement for the proposed action. The environmental impact statement
will evaluate the environmental impacts for construction, operation and
decommissioning of NWMI's radioisotope production facility. This review
will cover all activities at NWMI's radioisotope production facility,
including those under 10 CFR parts 50 and 70.
The docketing of the application does not predict whether the NRC
will grant or deny the requested construction permit. If the NRC finds
that NWMI's construction permit application meets the applicable
standards of the AEA and the NRC's regulations, and that required
notifications to other agencies and bodies have been made, the NRC will
issue a construction permit for a production facility under 10 CFR part
50, in the form and containing conditions and limitations that the NRC
finds appropriate and necessary.
This notice only addresses the start of a review to determine
whether the NRC will issue a construction permit for the proposed NWMI
facility. In order to operate and produce radioisotopes in its
facility, a separate application must be submitted by NWMI for the
NRC's review and approval, and, if docketed, would be the subject of a
separate FRN.

Dated at Rockville, Maryland, this 24 day of December, 2015.

For the Nuclear Regulatory Commission.
Michael F. Balazik,
Chief (Acting), Research and Test Reactors Licensing Branch, Division
of Policy and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2015-33025 Filed 12-31-15; 8:45 am]
BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.